He also prescribed a "cautious path" over the issue saying there have been different views among the scientists and civil society.
Reddy was speaking at the Biotechnology Industry Research Assistance Council's (BIRAC) foundation day.
"We are trying to build a consensus among various stakeholders like parliamentarians, NGOs, scientists and others. We will successfully arrive at a consensus very soon," he said.
The issue of GM crop has been a contentious one as industrialists and environmentalists have locked horns over it.
Reddy said India's Biotechnology sector has grown steadily over the last decade from USD 500 million in 2003 to USD 4 billion in 2011-12.
"Today Indian Biotech stands fourth in term of volume and 13th in terms of value, holding 2 per cent of global biotech industry share. Ranked third in the Asia-Pacific region after Japan and Korea, Biotech Industry in India has registered a CAGR of 14.75 per cent during the last five years," he said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
